Sanara MedTech Inc.
NASDAQSMTI dropped the numbers after the close on May 11 — and the print came in ahead of expectations on both the top and bottom lines. Q1 revenue hit $27.8M, above the $26.8M consensus. EPS of $0.05 beat the $(0.04) estimate by a wide margin. The company held its full-year 2026 sales guidance at $116M–$121M, bracketing the Street's $117.3M estimate, and guided Q2 sales to $28.5M–$29.5M…
Snapshot as of 25 Jun 2026
SMTI dropped the numbers after the close on May 11 — and the print came in ahead of expectations on both the top and bottom lines. Q1 revenue hit $27.8M, above the $26.8M consensus. EPS of $0.05 beat the $(0.04)…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SMTI — free to start on ORTEX.
Sign up for free →Open SMTI on ORTEX